These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24045841)

  • 1. A novel intermediate mucolipidosis II/IIIαβ caused by GNPTAB mutation in the cytosolic N-terminal domain.
    Leroy JG; Sillence D; Wood T; Barnes J; Lebel RR; Friez MJ; Stevenson RE; Steet R; Cathey SS
    Eur J Hum Genet; 2014 May; 22(5):594-601. PubMed ID: 24045841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of predominant GNPTAB gene mutations in Eastern Chinese patients with mucolipidosis II/III and a prenatal diagnosis of mucolipidosis II.
    Wang Y; Ye J; Qiu WJ; Han LS; Gao XL; Liang LL; Gu XF; Zhang HW
    Acta Pharmacol Sin; 2019 Feb; 40(2):279-287. PubMed ID: 29872134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of mucolipidosis II/III GNPTAB missense mutations identifies domains of UDP-GlcNAc:lysosomal enzyme GlcNAc-1-phosphotransferase involved in catalytic function and lysosomal enzyme recognition.
    Qian Y; van Meel E; Flanagan-Steet H; Yox A; Steet R; Kornfeld S
    J Biol Chem; 2015 Jan; 290(5):3045-56. PubMed ID: 25505245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucolipidosis II (I-cell disease) and mucolipidosis IIIA (classical pseudo-hurler polydystrophy) are caused by mutations in the GlcNAc-phosphotransferase alpha / beta -subunits precursor gene.
    Kudo M; Brem MS; Canfield WM
    Am J Hum Genet; 2006 Mar; 78(3):451-63. PubMed ID: 16465621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucolipidosis II and III alpha/beta in Brazil: analysis of the GNPTAB gene.
    Cury GK; Matte U; Artigalás O; Alegra T; Velho RV; Sperb F; Burin MG; Ribeiro EM; Lourenço CM; Kim CA; Valadares ER; Galera MF; Acosta AX; Schwartz IV
    Gene; 2013 Jul; 524(1):59-64. PubMed ID: 23566849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lysosomal storage disorders mucolipidosis type II, type III alpha/beta, and type III gamma: Update on GNPTAB and GNPTG mutations.
    Velho RV; Harms FL; Danyukova T; Ludwig NF; Friez MJ; Cathey SS; Filocamo M; Tappino B; Güneş N; Tüysüz B; Tylee KL; Brammeier KL; Heptinstall L; Oussoren E; van der Ploeg AT; Petersen C; Alves S; Saavedra GD; Schwartz IV; Muschol N; Kutsche K; Pohl S
    Hum Mutat; 2019 Jul; 40(7):842-864. PubMed ID: 30882951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of 22 novel UDP-N-acetylglucosamine-1-phosphate transferase alpha- and beta-subunit (GNPTAB) gene mutations causing mucolipidosis types IIalpha/beta and IIIalpha/beta in 46 patients.
    Tappino B; Chuzhanova NA; Regis S; Dardis A; Corsolini F; Stroppiano M; Tonoli E; Beccari T; Rosano C; Mucha J; Blanco M; Szlago M; Di Rocco M; Cooper DN; Filocamo M
    Hum Mutat; 2009 Nov; 30(11):E956-73. PubMed ID: 19634183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotype and genotype in mucolipidoses II and III alpha/beta: a study of 61 probands.
    Cathey SS; Leroy JG; Wood T; Eaves K; Simensen RJ; Kudo M; Stevenson RE; Friez MJ
    J Med Genet; 2010 Jan; 47(1):38-48. PubMed ID: 19617216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of the GNPTAB and GNPTG genes in 13 patients with mucolipidosis type II or type III - identification of eight novel mutations.
    Encarnação M; Lacerda L; Costa R; Prata MJ; Coutinho MF; Ribeiro H; Lopes L; Pineda M; Ignatius J; Galvez H; Mustonen A; Vieira P; Lima MR; Alves S
    Clin Genet; 2009 Jul; 76(1):76-84. PubMed ID: 19659762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three novel homozygous mutations in the GNPTG gene that cause mucolipidosis type III gamma.
    Liu S; Zhang W; Shi H; Meng Y; Qiu Z
    Gene; 2014 Feb; 535(2):294-8. PubMed ID: 24316125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, biochemical and molecular characterization of Korean patients with mucolipidosis II/III and successful prenatal diagnosis.
    Yang M; Cho SY; Park HD; Choi R; Kim YE; Kim J; Lee SY; Ki CS; Kim JW; Sohn YB; Song J; Jin DK
    Orphanet J Rare Dis; 2017 Jan; 12(1):11. PubMed ID: 28095893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined in vitro and in silico analyses of missense mutations in GNPTAB provide new insights into the molecular bases of mucolipidosis II and III alpha/beta.
    Danyukova T; Ludwig NF; Velho RV; Harms FL; Güneş N; Tidow H; Schwartz IV; Tüysüz B; Pohl S
    Hum Mutat; 2020 Jan; 41(1):133-139. PubMed ID: 31579991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyses of disease-related GNPTAB mutations define a novel GlcNAc-1-phosphotransferase interaction domain and an alternative site-1 protease cleavage site.
    Velho RV; De Pace R; Klünder S; Sperb-Ludwig F; Lourenço CM; Schwartz IV; Braulke T; Pohl S
    Hum Mol Genet; 2015 Jun; 24(12):3497-505. PubMed ID: 25788519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of two novel variants in GNPTAB underlying mucolipidosis II in a Pakistani family.
    Khan MA; Zubaida B; Karim N; Cheema HA; Naeem M
    J Pediatr Endocrinol Metab; 2020 May; 33(5):647-651. PubMed ID: 32238606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel splice site mutation in the GNPTAB gene in an Iranian patient with mucolipidosis II α/β.
    Hashemi-Gorji F; Ghafouri-Fard S; Salehpour S; Yassaee VR; Miryounesi M
    J Pediatr Endocrinol Metab; 2016 Aug; 29(8):991-3. PubMed ID: 27180337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GNPTAB c.2404C > T nonsense mutation in a patient with mucolipidosis III alpha/beta: a case report.
    Ho CC; Tsung LL; Liu KT; Poon WT
    BMC Med Genet; 2018 Sep; 19(1):162. PubMed ID: 30208878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of 30 novel pathogenic variations in 69 unrelated Indian patients with Mucolipidosis Type II and Type III.
    Pasumarthi D; Gupta N; Sheth J; Jain SJMN; Rungsung I; Kabra M; Ranganath P; Aggarwal S; Phadke SR; Girisha KM; Shukla A; Datar C; Verma IC; Puri RD; Bhavsar R; Mistry M; Sankar VH; Gowrishankar K; Agrawal D; Nair M; Danda S; Soni JP; Dalal A
    J Hum Genet; 2020 Nov; 65(11):971-984. PubMed ID: 32651481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MUCOLIPIDOSIS II INFANTS PRESENTING WITH SKELETAL DEFORMITIES MIMICKING RICKETS AND A NEW MUTATION IN GNPTAB GENE.
    Nur BG; Erdogan Y; Curek Y; Akcakus M; Oygur N; Bircan I; Mihci E
    Genet Couns; 2016; 27(3):373-380. PubMed ID: 30204966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GNPTAB missense mutations cause loss of GlcNAc-1-phosphotransferase activity in mucolipidosis type II through distinct mechanisms.
    Ludwig NF; Velho RV; Sperb-Ludwig F; Acosta AX; Ribeiro EM; Kim CA; Gandelman Horovitz DD; Boy R; Rodovalho-Doriqui MJ; Lourenço CM; Santos ES; Braulke T; Pohl S; Schwartz IVD
    Int J Biochem Cell Biol; 2017 Nov; 92():90-94. PubMed ID: 28918368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucolipidosis II-related mutations inhibit the exit from the endoplasmic reticulum and proteolytic cleavage of GlcNAc-1-phosphotransferase precursor protein (GNPTAB).
    De Pace R; Coutinho MF; Koch-Nolte F; Haag F; Prata MJ; Alves S; Braulke T; Pohl S
    Hum Mutat; 2014 Mar; 35(3):368-76. PubMed ID: 24375680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.